glp 1 peptide microdosing GLP-1 Microdosing: A Medical Perspective on 2025's Most Discussed Wellness Trend Microdosing GLP-1s: Safety, Dosage, Side

Hypertension 42(5):10501065

But the same trial flagged more atrial fibrillation, more blood clots, and, in a follow-up, more broken bones, most of them from ordinary falls, for reasons nobody has fully explained (New England Journal of Medicine, 2024)

Justin Perron, a specialist plastic surgeon in Australia, said hes fielded a surge in vaginal rejuvenation consultation appointments as GLP-1 drugs have grown in popularity

In fact, the largest weight loss trials for all three medications were conducted in people without diabetes

[1] [2] As of 20242025, retatrutide remains under clinical investigation and has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, nor by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for routine clinical use